Literature DB >> 17050659

Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice.

Sharon L Eastwood1, Louisa Lyon, Lydia George, Annie Andrieux, Didier Job, Paul J Harrison.   

Abstract

Stable tubule-only polypeptide (STOP) proteins are a family of microtubule associated proteins (MAPs) important in microtubule stabilization. Data indicating a role for microtubules in synaptic function has come from studies of the STOP null mouse, which exhibits synaptic deficits, in association with behavioural changes that are alleviated by antipsychotic treatment. These findings suggested that STOP mutant mice may be useful in studies of synaptic function, and could be especially relevant to schizophrenia, postulated to be a disorder of the synapse. Moreover, a genetic association between STOP and schizophrenia has been reported. This study aimed to further characterize synaptic alterations in STOP null and heterozygous mice. Using in situ hybridization histochemistry, the mRNA expression of three pre-synaptic (synaptophysin; growth associated protein-43 (GAP-43); vesicular glutamate transporter-1 (VGlut1)) and two post-synaptic (spinophilin; MAP2) proteins, was quantified in female STOP null (n = 7), heterozygous (n = 5) and wild type (n = 6) mice. For STOP null and heterozygous mice, synaptophysin, VGlut1, GAP-43 and spinophilin mRNAs were decreased in the hippocampus, whilst in addition in the null mice, synaptophysin, VGlut1 and spinophilin mRNAs were decreased in the cerebellum. Alterations in synaptic protein mRNA expression were also detected in the frontal and occipital cortex. MAP2 mRNA expression was unchanged in all brain regions. The profile of mRNA changes is broadly similar to that observed in schizophrenia. Together the data provide supporting evidence for a role for microtubules in synaptic function, and suggest that STOP, or other microtubule proteins, may contribute to the synaptic pathology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050659     DOI: 10.1177/0269881106068825

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  15 in total

1.  Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice.

Authors:  Kosuke Kajitani; Michael Thorne; Michel Samson; George S Robertson
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

Review 2.  ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.

Authors:  Amrita Ramkumar; Brigette Y Jong; Kassandra M Ori-McKenney
Journal:  Dev Dyn       Date:  2017-10-27       Impact factor: 3.780

3.  Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia-ischemia.

Authors:  Luodan Yang; Yan Dong; Chongyun Wu; Yong Li; Yichen Guo; Baocheng Yang; Xuemei Zong; Michael R Hamblin; Timon C-Y Liu; Quanguang Zhang
Journal:  J Biophotonics       Date:  2019-02-14       Impact factor: 3.207

4.  Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.

Authors:  David Delotterie; Geoffrey Ruiz; Jacques Brocard; Annie Schweitzer; Corinne Roucard; Yann Roche; Marie-Françoise Suaud-Chagny; Karine Bressand; Annie Andrieux
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

5.  Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice.

Authors:  Ryosuke Hanaya; Estelle Koning; Arielle Ferrandon; Annie Schweitzer; Annie Andrieux; Astrid Nehlig
Journal:  J Neurosci Res       Date:  2008-03       Impact factor: 4.164

6.  Gene expression in the anterior cingulate cortex and amygdala of adolescent marmoset monkeys following parental separations in infancy.

Authors:  Amanda J Law; Qi Pei; Joram Feldon; Christopher R Pryce; Paul J Harrison
Journal:  Int J Neuropsychopharmacol       Date:  2008-12-23       Impact factor: 5.176

Review 7.  Role of Microtubule-Associated Protein in Autism Spectrum Disorder.

Authors:  Qiaoqiao Chang; Hua Yang; Min Wang; Hongen Wei; Fengyun Hu
Journal:  Neurosci Bull       Date:  2018-06-23       Impact factor: 5.203

8.  Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphine.

Authors:  Alexandre Charlet; Arnaud H Muller; Alexis Laux; Véronique Kemmel; Annie Schweitzer; Jean-Christophe Deloulme; Denise Stuber; François Delalande; Enrica Bianchi; Alain Van Dorsselaer; Dominique Aunis; Annie Andrieux; Pierrick Poisbeau; Yannick Goumon
Journal:  Mol Pain       Date:  2010-12-20       Impact factor: 3.395

9.  Expression of kinase interacting with stathmin (KIS, UHMK1) in human brain and lymphoblasts: Effects of schizophrenia and genotype.

Authors:  Greg C Bristow; Tracy A Lane; Mary Walker; Li Chen; Yoshi Sei; Thomas M Hyde; Joel E Kleinman; Paul J Harrison; Sharon L Eastwood
Journal:  Brain Res       Date:  2009-09-09       Impact factor: 3.252

10.  Reduced expression of STOP/MAP6 in mice leads to cognitive deficits.

Authors:  Julien Volle; Jacques Brocard; Mohamed Saoud; Sylvie Gory-Faure; Jérôme Brunelin; Annie Andrieux; Marie-Françoise Suaud-Chagny
Journal:  Schizophr Bull       Date:  2012-09-20       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.